Efficacy and Safety of a Pegasparaginase-Based Chemotherapy Regimen vs an L-asparaginase–Based Chemotherapy Regimen for Newly Diagnosed Advanced Extranodal Natural Killer/T-Cell LymphomaXinhua Wang, Mingzhi Zhang, Lei Zhang et al.|JAMA Oncology|2022Cited by 61
Orelabrutinib-bruton tyrosine kinase inhibitor-based regimens in the treatment of central nervous system lymphoma: a retrospective studyJingjing Wu, Mingzhi Zhang, Zhenchang Sun et al.|Investigational New Drugs|2022Cited by 44
Lymphoma associated hemophagocytic syndrome: A single‑center retrospective studyYu Chang, Mingzhi Zhang, Meng Cui et al.|Oncology Letters|2018Cited by 43
Six1 mediates resistance to paclitaxel in breast cancer cellsZhaoming Li, Mingzhi Zhang, Tian Tian et al.|Biochemical and Biophysical Research Communications|2013Cited by 38
The efficacy and safety of gemcitabine, cisplatin, prednisone, thalidomide versus <scp>CHOP</scp> in patients with newly diagnosed peripheral T‐cell lymphoma with analysis of biomarkersLing Li, Mingzhi Zhang, Wenjing Duan et al.|British Journal of Haematology|2017Cited by 35